Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
1.
Actas Dermosifiliogr ; 114(5): 437-441, 2023 May.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-36871819

RESUMO

We describe 28 patients who experienced effluvium with previously unreported features shortly after hair transplant surgery. Notable features were as follows: a) a linear morphology; b) immediate onset (1-3 days); c) association with dense-pack grafting in areas of receding hairline at the temples (Mickey Mouse pattern); d) a progressive increase in the diameter of the hair loss line (wave-like pattern); e) in some cases, subsequent concentric linear effluvium on the crown (donut pattern); and f) other forms of previously unreported immediate-onset effluvium. The linear morphology could be the result of dense packing, which can cause perilesional hypoxia and loss of miniaturized hairs around the recipient area. Since linear hair loss can cause patient concern about graft failure, we recommend taking images of transplanted and nontransplanted areas immediately after surgery and warning patients in advance about these transient effects, which are fully reversed in 3 months.


Assuntos
Alopecia , Cabelo , Humanos , Cabelo/transplante , Alopecia/etiologia , Transplante de Pele
2.
Clin Investig Arterioscler ; 36(1): 12-21, 2024.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-37625908

RESUMO

INTRODUCTION: Current guidelines recommend cardiovascular risk assessment as a preventive measure for cardiovascular diseases, whose fundamental etiology is arteriosclerosis. One of the tools used to estimate risk in clinical practice are atherogenic indices (AI), ratios between lipid fractions with well-established reference ranges. Despite its widespread use, there is still limited information on its clinical utility. In recent years, some research has reinforced the role of inflammation in the etiology and chronicity of the atherosclerotic process. The inclusion of inflammatory parameters in the AI calculation could improve its diagnostic performance in the detection of arteriosclerosis. We sought to evaluate a new AI as a ratio between C-reactive protein (CRP) values and high-density lipoprotein cholesterol (HDL) values. METHODS: A total of 282 asymptomatic patients with no history of cardiovascular disease were included in the study. Laboratory tests with lipid profile and CRP, and carotid ultrasound to assess the presence of atheromatosis were performed in all of them. The new AI is established as the ratio between non-ultrasensitive CRP value in mg/dL (multiplied by 100) and HDL value in mg/dL. It was compared with the Castelli I and II indices, and the plasma atherogenic index. The optimal cut-off point of the new AI was value=1 as determined by ROC curve, with an area under the curve of 0.678 (95% CI 0.60-0.75; p<0.001). RESULTS: Mean age of patients was 60.4±14.5 years. A total of 118 patients (41.8% of total) had carotid arteriosclerosis. When evaluating the diagnostic performance of different AIs, we found that CRP·100/HDL ratio showed the highest values of sensitivity and positive predictive value (0.73 and 0.68, respectively) compared to the Castelli I and II indices, and the plasma atherogenic index. It was also the only predictor of carotid atheromatosis both when considering its values quantitatively (with OR 1.4 [95% CI 1.1-1.7]; p=0.005), and qualitatively (with OR 2.9 [95% CI 1.5-5.5]; p<0.001) in patients with a CRP·100/HDL ratio>1. CONCLUSIONS: The new PCR·100/HDL index showed the best diagnostic performance in the detection of carotid atheromatosis compared to other classic AIs in this Spanish population of asymptomatic patients.


Assuntos
Aterosclerose , Doenças Cardiovasculares , Doenças das Artérias Carótidas , Humanos , Pessoa de Meia-Idade , Idoso , Proteína C-Reativa/metabolismo , Biomarcadores , Fatores de Risco , Aterosclerose/diagnóstico , Aterosclerose/etiologia , Doenças das Artérias Carótidas/diagnóstico por imagem , HDL-Colesterol , Doenças Cardiovasculares/complicações
3.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-38702206

RESUMO

INTRODUCTION AND OBJECTIVES: The association between HDL cholesterol (HDL-C) levels and death from cardiovascular disease follows a U-shaped pattern, increasing at the extremes. The objective of the study was to characterize a sample of subjects with extreme hyperalphalipoproteinemia (HAE). MATERIAL AND METHODS: 53 cases with HAE were recruited, 24 women (HDL-C>135mg/ dL) and 29 men (HDL-C>116mg/ dL). A detailed medical history was taken and questionnaires on adherence to the Mediterranean diet and physical activity were collected. Carotid ultrasounds were performed to detect the presence of suclinical atherosclerosis. RESULTS: The most prevalent cardiovascular risk factor (CVRF) was dyslipidemia (64%) with no significant differences between men and women, unlike hypertension (21% in women, versus 55% in men, p=0.01) and others CVRF, for example, diabetes. 7% of the series had previous cardiovascular disease, women had higher LDL cholesterol (p=0.002) and HDL-C than men (without significant differences). Plaque was detected in 53% of cases, being more prevalent in men. Patients with plaque were older, drank more alcohol and smoked more (p<0.05). CONCLUSIONS: Men had a higher prevalence of CVRF than women, except for dyslipidemia. Subclinical atherosclerosis occurred in more than half of the series. Age, alcohol consumption and smoking were independently associated with the presence of plaque, however, our data do not show a significant influence of HDL-C levels.

4.
Rev Esp Cardiol (Engl Ed) ; 77(9): 723-733, 2024 Sep.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-38336154

RESUMO

INTRODUCTION AND OBJECTIVES: The optimal approach for persistent atrial fibrillation (AF) ablation remains unknown. In patients with persistent AF, we compared an ablation strategy based on pulmonary vein isolation (PVI) plus ablation of drivers (PVI+D), with a conventional PVI-only approach performed in a 1:1 propensity score-matched cohort. METHODS: Drivers were subjectively identified using conventional high-density mapping catheters (IntellaMap ORION, PentaRay NAV or Advisor HD Grid), without dedicated software, as fractionated continuous or quasicontinuous electrograms on 1 to 2 adjacent bipoles, which were ablated first; and as sites with spatiotemporal dispersion (the entire cycle length comprised within the mapping catheter) plus noncontinuous fractionation, which were only targeted in patients without fractionated continuous electrograms, or without AF conversion after ablation of fractionated continuous electrograms. Ablation included PVI plus focal or linear ablation targeting drivers. RESULTS: A total of 50 patients were included in each group (61±10 years, 25% women). Fractionated continuous electrograms were found and ablated in 21 patients from the PVI+D group (42%), leading to AF conversion in 7 patients. In the remaining 43 patients, 143 sites with spatiotemporal dispersion plus noncontinuous fractionation were targeted. Globally, AF conversion was achieved in 21 patients (42%). The PVI+D group showed lower atrial arrhythmia recurrences at 1 year of follow-up (30.6% vs 48%; P=.048) and at the last follow-up (46% vs 72%; P=.013), and less progression to permanent AF (10% vs 40%; P=.001). CONCLUSIONS: Subjective identification and ablation of drivers, added to PVI, increased 1-year freedom from atrial arrhythmia and decreased long-term recurrences and progression to permanent AF.


Assuntos
Fibrilação Atrial , Ablação por Cateter , Veias Pulmonares , Humanos , Fibrilação Atrial/cirurgia , Fibrilação Atrial/fisiopatologia , Fibrilação Atrial/diagnóstico , Feminino , Masculino , Ablação por Cateter/métodos , Pessoa de Meia-Idade , Veias Pulmonares/cirurgia , Resultado do Tratamento , Técnicas Eletrofisiológicas Cardíacas/métodos , Seguimentos , Frequência Cardíaca/fisiologia , Idoso , Pontuação de Propensão , Recidiva , Sistema de Condução Cardíaco/fisiopatologia , Sistema de Condução Cardíaco/cirurgia
5.
Endocrinol Diabetes Nutr (Engl Ed) ; 68(6): 372-380, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34742470

RESUMO

INTRODUCTION: Bariatric surgery aims to reduce weight and resolve the comorbidities associated with obesity. Few studies have assessed mid/long-term changes in lipid profile with sleeve gastrectomy versus gastric bypass. This study was conducted to assess and compare changes in lipid profile with each procedure after 60 months. METHODS: This was an observational, retrospective study of analytical cohorts enrolling 100 patients distributed into two groups: 50 had undergone gastric bypass (GBP) surgery and 50 sleeve gastrectomy (SG) surgery. Total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglyceride (TG) levels were measured before surgery and at 1, 6, 12, 24, 36, 48, and 60 months. Weight loss and the resolution of dyslipidemia with each of the procedures were also assessed. RESULTS: Ninety-five of the 100 patients completed follow-up. At 60 months, TC and LDL levels had significantly decreased in the BPG group (167.42 ±â€¯31.22 mg/dl and 88.06 ±â€¯31.37 mg/dl, respectively), while there were no differences in the SG group. Increased HDL levels were seen with both procedures (BPG: 62.69 ±â€¯16.3 mg/dl vs. SG: 60.64 ±â€¯18.73 mg/dl), with no difference between the procedures. TG levels decreased in both groups (BPG: 86.06 ±â€¯56.57 mg/dl vs. SG: 111.09 ±â€¯53.08 mg/dl), but values were higher in the BPG group (P < .05). The percentage of overweight lost (PSP) was higher in the BPG group: 75.65 ±â€¯22.98 mg/dl vs. the GV group: 57.83 ±â€¯27.95 mg/dl. CONCLUSION: Gastric bypass achieved better mid/long-term results in terms of weight reduction and the resolution of hypercholesterolemia as compared to sleeve gastrectomy. While gastric bypass improved all lipid profile parameters, sleeve gastrectomy only improved HDL and triglyceride levels.


Assuntos
Cirurgia Bariátrica , Derivação Gástrica , Lipídeos/sangue , Obesidade Mórbida , Gastrectomia , Humanos , Lipoproteínas HDL/sangue , Obesidade Mórbida/cirurgia , Estudos Retrospectivos , Triglicerídeos/sangue , Redução de Peso
6.
Clin Investig Arterioscler ; 33(3): 117-126, 2021.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-33328138

RESUMO

BACKGROUND: Bempedoic acid is a novel non-statin drug that was developed to treat hyperlipidemia in combination with other lipid-lowering drugs in those patients who need additional lipid lowering. OBJECTIVES: (1) To investigate the lipid efficacy of bempedoic acid; (2) to analyze the anti-inflammatory effects of bempedoic acid estimated through high sensitivity C-reactive protein (hsCRP). METHODS: We performed a meta-analysis including randomized trials of bempedoic acid therapy, reporting low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), apolipoprotein B and hsCRP with a minimum of 4 weeks of follow-up. The primary endpoint was defined as the percentage change in lipids and hsCRP levels measured from baseline to follow-up, comparing groups of subjects on bempedoic acid versus placebo. RESULTS: Seven eligible trials of bempedoic acid (3892 patients) were included. The bempedoic acid therapy was associated with a significant reduction in LDL-C levels [-20.3% (CI 95% -23.5 to -17.1)]; I2=43%]. Similarly, a significant percentage reduction in the apolipoprotein B levels [-14.3% (CI 95% -16.4 to -12.1)]; p<0.05; I2=46%], non-HDL-C levels [-15.5% (CI 95% -18.1 to -13.0)]; p<0.05; I2=53%] and hsCRP [-23.4% (CI 95% -32.6 to -14.2)]; p<0.05; I2=69%] was demonstrated with the bempedoic acid use. The sensitivity analysis showed that the results were robust. CONCLUSION: Our data suggests that the use of bempedoic acid significantly reduces the levels of all atherogenic lipid markers, including LDL-C, non-HDL-C and apolipoprotein B. Furthermore, considering hsCRP levels, the drug produces an anti-inflammatory effect.


Assuntos
Aterosclerose , Ácidos Dicarboxílicos/uso terapêutico , Ácidos Graxos/uso terapêutico , Hipercolesterolemia , Hipolipemiantes/uso terapêutico , Preparações Farmacêuticas , Anti-Inflamatórios/uso terapêutico , Apolipoproteínas B , Aterosclerose/tratamento farmacológico , Proteína C-Reativa , Colesterol , LDL-Colesterol , Humanos , Hipercolesterolemia/tratamento farmacológico , Inflamação/tratamento farmacológico , Lipídeos
7.
Clin Investig Arterioscler ; 32(5): 209-218, 2020.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32037300

RESUMO

In general, both European and American clinical guidelines have addressed the management of atherogenic dyslipidaemia in an unconvincing and even superficial way, largely because of the available therapeutic limitations. Consequently, this type of dyslipidaemia is underdiagnosed, under-treated, and under-controlled. Given the recent presentation of the 2019 guidelines of the European Atherosclerosis Society and the European Society of Cardiology on the management of dyslipidaemias, it seems appropriate to examine its position with respect to atherogenic dyslipidaemia and/or its main components, the increase in triglyceride-rich lipoproteins, and the decrease of high-density lipoprotein cholesterol.


Assuntos
Aterosclerose/prevenção & controle , Dislipidemias/terapia , Guias de Prática Clínica como Assunto , Aterosclerose/etiologia , HDL-Colesterol/sangue , Dislipidemias/sangue , Dislipidemias/complicações , Europa (Continente) , Humanos , Triglicerídeos/sangue
8.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-31147299

RESUMO

BACKGROUND: Recently, a new approach of autologous chondrocyte implantation technique (using as biomaterial a collagen type i/iii membrane) based on increasing cell density called HD-ACI (High Density Autologous Chondrocyte Implantation) has been described. The objective of this paper was to study the clinical outcome and incidence of subchondral bone oedema in patients with cartilage lesions in the knee treated with HD-ACI at 1-2 years of follow-up. METHODS: This is a retrospective study performed with forty patients with chondral injuries grade iii-iv. All patients were treated with HD-ACI with a cellular dose of 5×106 chondrocytes /cm2 of lesion. The subjective perception of improvement of symptoms and functionality was measured with the IKDC score (International Knee Documentation Committee). The presence of bone oedema was assessed at 6, 12 and 24 months of follow-up by magnetic resonance imaging. RESULTS: IKDC values showed a significant improvement at 12 and 24 months (P<.001). The mean difference of IKDC between the baseline visit and 12 months was 26.3 points, and 31.6 points at 24 months. Twenty-seven point five percent of the patients presented subchondral bone oedema at 2 years of follow-up. CONCLUSIONS: HD-ACI is an effective and safe treatment that improves pain, clinical perception and functionality of the joint. No correlation was found between the presence of bone oedema and the patients' clinical outcome.


Assuntos
Doenças Ósseas/etiologia , Condrócitos/transplante , Edema/etiologia , Articulação do Joelho/cirurgia , Complicações Pós-Operatórias/etiologia , Adulto , Feminino , Seguimentos , Humanos , Masculino , Estudos Retrospectivos , Fatores de Tempo , Transplante Autólogo/efeitos adversos , Transplante Autólogo/métodos
9.
Kinesiologia ; 42(4): 314-321, 20231215.
Artigo em Espanhol, Inglês | LILACS-Express | LILACS | ID: biblio-1552543

RESUMO

Introducción. Las distrofias musculares son trastornos genéticamente heredados que causan la degeneración progresiva de las fibras musculares. La electromiografía, especialmente la de alta densidad, se ha convertido en una herramienta valiosa para el diagnóstico y el estudio de la función muscular de trastornos neuromusculares. Objetivo. Describir y discutir el uso actual de esta técnica en las distrofias musculares. Métodos. Se realizó un Scoping Review sobre el uso de electromiografía de alta densidad en personas con distrofia muscular. Se buscó en PubMed, ScienceDirect, Scopus, Web of Science y Biblioteca Cochrane Plus, usando palabras clave en inglés y español. Se consideraron estudios desde 2015 a la fecha. Se identificaron tres artículos que cumplían con los criterios establecidos. Resultados. Los estudios se centraron en aplicaciones clínicas y de bioingeniería para personas con distrofia muscular de Duchenne y distrofia facioescapulohumeral. Los resultados sugieren que variables como la fatiga, la activación temporo-espacial y la dimensionalidad en gestos motores están determinados por la degeneración de las fibras musculares, el reemplazo por tejido fibrótico, los cambios adaptativos y la debilidad muscular progresiva característica de este grupo de condiciones. Se resalta la utilidad de la electromiografía de alta densidad en la evaluación y el manejo de la distrofia muscular. Conclusiones. El uso de esta técnica en estos trastornos neuromusculares sigue en aumento, pero se hace necesario explorar más aristas para ampliar su uso como herramienta en el estudio y en el desarrollo de intervenciones terapéuticas en esta condición por parte de profesionales de la salud.


Background. Muscular dystrophies are genetically inherited disorders that cause progressive degeneration of muscle fibers. Electromyography, especially high-density electromyography, has become a valuable tool for the diagnosis and study of muscle function in neuromuscular disorders, so the objective of this study is to describe and discuss the current use of this technique in muscular dystrophies. Methods. A Scoping Review was carried out on the use of high density electromyography in people with muscular dystrophy. PubMed, ScienceDirect, Scopus, Web of Science, and Cochrane Plus Library were searched using keywords in English and Spanish. Studies from 2015 to date were considered. Three articles were identified that met the established criteria. Results. The studies focused on clinical and bioengineering applications for people with Duchenne muscular dystrophy and facioscapulohumeral dystrophy. The results suggest that variables such as fatigue, temporal-spatial activation and dimensionality in motor gestures are determined by the degeneration of muscle fibers, replacement by fibrotic tissue, adaptive changes and progressive muscle weakness characteristic of this group of conditions. The usefulness of high-density electromyography in the evaluation and management of muscular dystrophy is highlighted. Conclusions. The use of this technique in these neuromuscular disorders continues to increase, but it is necessary to explore more aspects to expand its use as a tool in the management of this condition.

10.
Actas dermo-sifiliogr. (Ed. impr.) ; 114(5): 437-441, mayo 2023. ilus, tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-220792

RESUMO

Describimos 28 pacientes que desarrollaron una forma de efluvio postrasplante capilar con características no descritas en la literatura: a) morfología lineal; b) aparición inmediata (1-3 días); c) asociación con ‘dense packing’ en entradas (‘signo de Mickey Mouse’); d) progresión del diámetro de la línea (patrón ‘wave-like’); e) posible adición posterior de efluvio lineal concéntrico a vértex (‘signo del Donut’), y f) además de otros efluvios tampoco publicados por su inmediatez de aparición. La morfología lineal podría ser el resultado de la alta densidad colocada en nuestros pacientes, provocando hipoxia perilesional y efluvio de las unidades foliculares miniaturizadas que rodean la zona receptora. Debido a que la línea alopécica provoca inseguridad a los pacientes sobre una posible no colocación de injertos, recomendamos iconografía postoperatoria inmediata demostrando unión de áreas trasplantada y no trasplantada, así como la explicación previa al paciente de este fenómeno transitorio y completamente reversible en 3 meses (AU)


We describe 28 patients who experienced effluvium with previously unreported features shortly after hair transplant surgery. Notable features were as follows: a) a linear morphology; b) immediate onset (1-3 days); c) association with dense-pack grafting in areas of receding hairline at the temples (Mickey Mouse pattern); d) a progressive increase in the diameter of the hair loss line (wave-like pattern); e) in some cases, subsequent concentric linear effluvium on the crown (donut pattern); and f) other forms of previously unreported immediate-onset effluvium. The linear morphology could be the result of dense packing, which can cause perilesional hypoxia and loss of miniaturized hairs around the recipient area. Since linear hair loss can cause patient concern about graft failure, we recommend taking images of transplanted and nontransplanted areas immediately after surgery and warning patients in advance about these transient effects, which are fully reversed in 3 months (AU)


Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Cabelo/transplante , Alopecia/cirurgia , Transplante de Pele , Resultado do Tratamento
11.
Actas dermo-sifiliogr. (Ed. impr.) ; 114(5): t437-t441, mayo 2023. ilus, tab
Artigo em Inglês | IBECS (Espanha) | ID: ibc-220793

RESUMO

We describe 28 patients who experienced effluvium with previously unreported features shortly after hair transplant surgery. Notable features were as follows: a) a linear morphology; b) immediate onset (1-3 days); c) association with dense-pack grafting in areas of receding hairline at the temples (Mickey Mouse pattern); d) a progressive increase in the diameter of the hair loss line (wave-like pattern); e) in some cases, subsequent concentric linear effluvium on the crown (donut pattern); and f) other forms of previously unreported immediate-onset effluvium. The linear morphology could be the result of dense packing, which can cause perilesional hypoxia and loss of miniaturized hairs around the recipient area. Since linear hair loss can cause patient concern about graft failure, we recommend taking images of transplanted and nontransplanted areas immediately after surgery and warning patients in advance about these transient effects, which are fully reversed in 3 months (AU)


Describimos 28 pacientes que desarrollaron una forma de efluvio postrasplante capilar con características no descritas en la literatura: a) morfología lineal; b) aparición inmediata (1-3 días); c) asociación con ‘dense packing’ en entradas (‘signo de Mickey Mouse’); d) progresión del diámetro de la línea (patrón ‘wave-like’); e) posible adición posterior de efluvio lineal concéntrico a vértex (‘signo del Donut’), y f) además de otros efluvios tampoco publicados por su inmediatez de aparición. La morfología lineal podría ser el resultado de la alta densidad colocada en nuestros pacientes, provocando hipoxia perilesional y efluvio de las unidades foliculares miniaturizadas que rodean la zona receptora. Debido a que la línea alopécica provoca inseguridad a los pacientes sobre una posible no colocación de injertos, recomendamos iconografía postoperatoria inmediata demostrando unión de áreas trasplantada y no trasplantada, así como la explicación previa al paciente de este fenómeno transitorio y completamente reversible en 3 meses (AU)


Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Cabelo/transplante , Alopecia/cirurgia , Transplante de Pele , Resultado do Tratamento
12.
Endocrinol Diabetes Nutr (Engl Ed) ; 65(2): 74-83, 2018 Feb.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-29290474

RESUMO

OBJECTIVE: To determine the behavior of the triglycerides/HDL-cholesterol ratio (TG/HDL) as a cardiometabolic risk marker in children and adolescents from Mérida, Venezuela. METHODS: A total of 1292 children and adolescents aged 7-18 years who attended educational institutions in the Libertador Municipality were enrolled into this study. Anthropometric measurements and blood pressure values were recorded. Fasting blood glucose, insulin and lipid levels were measured. The TG/HDL ratio, HOMA-IR, and QUICKI indexes were calculated. Subjects were categorized as with and without cardiometabolic risk based on the presence or absence of 2or more risk factors. Cut-off points for the TG/HDL ratio were determined by constructing ROC curves. RESULTS: Significantly higher mean TG/HDL ratios were found in pubertal (2.2 ± 1.7) as compared to prepubertal subjects (1.8 ± 1.5; P=.001), with no sex differences. Two or more risk factors were found in 14.7% (n=192) of the participants, in whom TG/HDL ratios were significantly higher as compared to those with no risk (3.5±2.9 versus 1.6±0.8 in prepubertal and 4.1 ± 3.5 versus 1.8 ± 0.9 in pubertal subjects; P=.0001). According to cardiometabolic risk, cut-off points for the TG/HDL ratio of 1.8 and 2.5 were found for prepubertal and pubertal children respectively. These cut-off points showed risks (odds ratio) higher than 2.5 for conditions such as metabolic syndrome, elevated non-HDL-C, abdominal obesity, and elevated HOMA-IR. CONCLUSION: In this sample of children and adolescents, an elevated TG/HDLc ratio was found to be a good marker for predicting cardiometabolic risk.


Assuntos
HDL-Colesterol/sangue , Triglicerídeos/sangue , Adolescente , Biomarcadores/sangue , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/epidemiologia , Criança , Estudos Transversais , Feminino , Humanos , Masculino , Doenças Metabólicas/sangue , Doenças Metabólicas/epidemiologia , Fatores de Risco , Saúde da População Urbana , Venezuela
13.
Rev. colomb. reumatol ; 30(2): 102-109, abr..-jun. 2023. tab, graf
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1576388

RESUMO

RESUMEN Introducción: La dislipidemia es la alteración metabólica más prevalente en el síndrome de Sjögren primario (SSP), se sugiere una asociación entre niveles bajos de colesterol de alta densidad (HDL) y la actividad de la enfermedad. Objetivos: El propósito de este estudio es describir las características del perfil lipídico y explorar la correlación entre sus componentes y la actividad del SSP. Materiales y métodos: Estudio descriptivo de corte trasversal, se revisaron las historias clí nicas de pacientes mayores de 18 años que asistieron al Hospital Universitario Clínica San Rafael, con criterios clasificatorios para SSP durante el periodo de enero del 2015 a diciembre del 2019. Para el análisis estadístico se utilizó el software RStudio versión 4.0.2. Se efectuó un análisis descriptivo de las variables clínico-demográficas y serológicas para evaluar la correlación entre ellas. Resultados: Se revisaron en total 250 historias clínicas, de las cuales, 35 cumplían con los criterios de inclusión. La edad promedio fue de 53,4 años; el 88,3% de la población fueron mujeres. La mediana del tiempo de enfermedad fue de 42 meses. Las medias de colesterol total, HDL, colesterol de baja densidad (LDL) y triglicéridos fueron de 191 mg/dL, 42,6 mg/dL, 118,9 mg/dL y 157 mg/dL, respectivamente. Se encontró un coeficiente de correlación de Pearson entre el índice de actividad ESSDAI y el colesterol HDL de -0,43 (IC 95% -0,67-0,12), valor p = 0,008. Se realizó un modelo lineal entre el índice de actividad ESSDAI total y el colesterol HDL, y como resultado se halló un coeficiente estimado de -0,17. La curva ROC, con un punto de segregación de colesterol HDL de 43,5 mg/dL, mostró un área bajo la curva (AUC) de 0,603 (IC 95% 0,40-0,80). Al excluir los pacientes con índice de masa corporal (IMC) alto, el AUC mejoró, con un punto de segregación de 38 mg/dL. Conclusiones: Los pacientes con niveles bajos de colesterol HDL mostraron mayores índices de actividad de la enfermedad, con un punto de corte menor a 43 mg/dL, siendo más marcado en pacientes con IMC normal.


ABSTRACT Introduction: Dyslipidaemia is the most prevalent metabolic disorder in primary Sjögren s syndrome (PSS) and an association between low HDL cholesterol levels and disease activity has been suggested. Objectives: The purpose of this study is to describe the characteristics of the lipid profile in patients with PSS and explore the correlation between the components of the lipid profile and the activity of the disease. Materials and methods: A descriptive cross-sectional study. We reviewed the medical records of patients over 18 years of age with criteria for PSS who attended the Hospital Universitario Clínica San Rafael during the period between January 2015 to December 2019. We used R-studio software version 4.0.2 for statistical analysis. A descriptive analysis of the clinical-demographic and serological variables was carried out to evaluate the correlation between them. Results: A total of 250 medical records were reviewed, of which 35 met the inclusion criteria. The average age was 53.4 years and 88.3% were women. The median duration of disease was 42 months. The mean values for total cholesterol, HDL, LDL and triglycerides were 191 mg/dL, 42.6 mg/dL, 118.9 mg/dL and 157 mg/dL respectively. A Pearson correlation coefficient of -.43 (95% CI -.67 to -.12) p-value = .008 was found between the ESSDAI activity index and HDL cholesterol. A linear model was performed between the total ESSDAI activity index and HDL cholesterol, finding an estimated coefficient of -.17. A ROC curve was performed with an HDL cholesterol segregation point of 43.5 mg/dL with an area under the curve of .603 (95% CI .40-.80). By excluding patients with high BMI, the area under the curve improved with a segregation point of 38 mg/dL. Conclusions: Patients with low levels of HDL cholesterol showed higher rates of disease activity, with a cut-off point lower than 43 mg/dL being more marked in patients with normal body mass index.

14.
Arch. cardiol. Méx ; Arch. cardiol. Méx;92(3): 334-341, jul.-sep. 2022. tab
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1393828

RESUMO

Abstract Objective: We evaluated whether cholesteryl ester transfer protein (CETP) gene polymorphisms are associated with the presence of coronary artery disease (CAD) and/or restenosis in patients with coronary stent. Methods: Two polymorphisms of the CETP gene [−971 A/G (rs4783961), and Taq1B A/G (rs708272)] were genotyped by 5'exonuclease TaqMan assays in 219 patients with CAD (66 patients with restenosis and 153 without restenosis) and 607 control individuals. Results: The distribution of polymorphisms was similar in patients with and without restenosis. However, when the whole group of patients (with and without restenosis) was compared to healthy controls, under dominant model, the G allele of the Taq1B A/G polymorphism was associated with increased risk of CAD (odds ratio [OR] = 1.48, pCDom = 0.032). In the same way, under codominant, dominant, and additive models, the A allele of the −971 A/G polymorphisms was associated with an increased risk of developing CAD (OR = 2.03, pCCo-dom = 0.022, OR = 1.83, pCDom = 0.008, and OR = 1.39, pCAdd = 0.011, respectively). In addition, the linkage disequilibrium showed that the "AG" haplotype was associated with increased risk of developing CAD (OR = 1.28, p = 0.03). Conclusion: This study demonstrates that CETP Taq1B A/G and CETP −971 A/G polymorphisms are associated with an increased risk of developing CAD, but no association with restenosis was observed.


Resumen Objetivo: Evaluamos si los polimorfismos del gen CETP están asociados con la presencia de enfermedad arterial coronaria (EAC) y/o restenosis en pacientes con stent coronario. Métodos: En este estudio se genotiparon dos polimorfismos del gen CETP [−971 A/G (rs4783961) y Taq1B A/G (rs708272)] mediante ensayos de 5'exonucleasa TaqMan en 219 pacientes con EAC (66 pacientes con restenosis y 153 sin restenosis), y 607 individuos de control. Resultados: La distribución de polimorfismos fue similar en pacientes con y sin restenosis. Sin embargo, cuando se comparó todo el grupo de pacientes (con y sin restenosis) con controles sanos, bajo el modelo dominante el alelo G del polimorfismo Taq1B A/G se asocia con un mayor riesgo de EAC (OR = 1.48, pCDom = 0.032). De la misma manera, bajo los modelos co-dominante, dominante y aditivo, el alelo A de los polimorfismos −971 A/G se asocia con un mayor riesgo de desarrollar EAC (OR = 2.03, pCCo-dom = 0.022, OR = 1.83, pCDom = 0,008 y OR = 1.39, pCAdd = 0.011, respectivamente). Adicionalmente, el desequilibrio de ligamiento mostró que el haplotipo "AG" se asocia con un mayor riesgo de desarrollar EAC (OR = 1.28, p = 0.03). Conclusión: En resumen, este estudio demuestra que los polimorfismos CETP Taq1B A/G y CETP −971 A/G están asociados con un mayor riesgo de desarrollar CAD, pero no se observó asociación con restenosis.

15.
ARS med. (Santiago, En línea) ; 47(1): 5-8, mar. 2022.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1380712

RESUMO

Introducción: las fracturas de pared de órbita pueden producir secuelas funcionales y estéticas. La indicación de reconstrucción quirúrgica, es indispensable para la recuperación de la motilidad y estética ocular. Los materiales reconstructivos más utilizados son los aloplásticos, como el titanio y el polietileno poroso de alta densidad (PPAD), el cual ha resultado exitoso en reconstrucción maxilofacial. El propósito de este estudio retrospectivo, es exponer los resultados tras el uso del PPAD en reconstrucciones orbitarias y sus posibles complicaciones. Materiales y métodos: se realizó una revisión retrospectiva de 22 pacientes donde se utilizó PPAD como material de reconstrucción en fracturas orbitarias. Se consideró para la indicación quirúrgica que el paciente presentara alguno de los siguientes signos: diplopía o síntomas vasovagales por atrapamiento muscular, restricciones en la motilidad ocular, enoftalmo mayor a 4mm. El material utilizado fue PPAD (Medpor Stryker®) puro en 17 casos y PPAD reforzado con una malla de titanio en el interior de su estructura (Medpor Titan Stryker®), en los 5 restantes. Resultados: se registraron 3 casos con complicaciones; ectropión, diplopía y ectropión con diplopía, los cuales todos fueron reversibles. No se registraron casos de infección ni complicaciones oftalmológicas postoperatoria. Discusión: los injertos autólogos fueron los primeros utilizados con resultados de compatibilidad y resistencia óptimos. El uso de PPAD como material de reconstrucción ha sido bien documentado con buenos resultados en términos de una baja incidencia de infección y óptima motilidad ocular a largo plazo.


Introduction: Orbital wall fractures can cause functional and aesthetic sequelae. When there is an indication for surgical reconstruction, this is essential for the recovery of ocular motility and aesthetics. The most commonly used reconstructive materials are alloplastics, such as titanium and porous high-density polyethylene (PPAD), which have been successful in maxillofacial reconstruction. The purpose of this retrospective study is to present the results and their possible complications in orbital reconstruction with PPAD. Materials and methods: a retrospective review of 22 patients in whom PPAD was used as reconstruction material for orbital fractures was performed. It was considered for the surgical indication that the patient presented any of the following signs: diplopia or vasovagal symptoms due to muscle entrapment, ocular motility restrictions, enophthalmos greater than 4mm. The material used was pure PPAD (Medpor Stryker®) in 17 cases, and PPAD reinforced with a titanium mesh inside its structure (Medpor Titan Stryker®), in the remaining 5. Results: 3 patients with complications were registered; ectropion, diplopia, and ectropion with diplopia, all of which were reversible. There were no cases of postoperative infection or ophthalmological complications. Discussion: Autologous grafts were the first used with optimal compatibility and resistance results. The use of PPAD as a reconstruction material has been well documented with good results in terms of a low incidence of infection and optimal long-term ocular motility

16.
Rev Esp Cardiol (Engl Ed) ; 70(9): 706-712, 2017 Sep.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28395996

RESUMO

INTRODUCTION AND OBJECTIVES: Rhythmia is a new nonfluoroscopic navigation system that is able to create high-density electroanatomic maps. The aim of this study was to describe the acute outcomes of atrial fibrillation (AF) ablation guided by this system, to analyze the volume provided by its electroanatomic map, and to describe its ability to locate pulmonary vein (PV) reconnection gaps in redo procedures. METHODS: This observational study included 62 patients who underwent AF ablation with Rhythmia compared with a retrospective cohort who underwent AF ablation with a conventional nonfluoroscopic navigation system (Ensite Velocity). RESULTS: The number of surface electrograms per map was significantly higher in Rhythmia procedures (12 125 ± 2826 vs 133 ± 21 with Velocity; P < .001), with no significant differences in the total procedure time. The Orion catheter was placed for mapping in 99.5% of PV (95.61% in the control group with a conventional circular mapping catheter; P = .04). There were no significant differences in the percentage of PV isolation between the 2 groups. In redo procedures, an ablation gap could be identified on the activation map in 67% of the reconnected PV (40% in the control group; P = .042). The measured left atrial volume was lower than that calculated by computed tomography (109.3 v 15.2 and 129.9 ± 13.2 mL, respectively; P < .001). There were no significant differences in the number of complications. CONCLUSIONS: The Rhythmia system is effective for AF ablation procedures, with procedure times and safety profiles similar to conventional nonfluoroscopic navigation systems. In redo procedures, it appears to be more effective in identifying reconnected PV conduction gaps.


Assuntos
Fibrilação Atrial/cirurgia , Ablação por Cateter/instrumentação , Veias Pulmonares/cirurgia , Idoso , Ablação por Cateter/métodos , Estudos de Coortes , Eletrocardiografia/métodos , Feminino , Fluoroscopia , Átrios do Coração/diagnóstico por imagem , Átrios do Coração/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Duração da Cirurgia , Tamanho do Órgão , Estudos Retrospectivos , Tomografia Computadorizada por Raios X
17.
Endocrinol Nutr ; 63(7): 327-32, 2016.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-27236636

RESUMO

BACKGROUND AND OBJECTIVE: The triglyceride/HDL cholesterol ratio, as a surrogate marker of insulin resistance, may be associated to presence of subclinical carotid atherosclerosis in postmenopausal women. The aim of this study was to explore this association. PATIENTS AND METHODS: Women (last menstrual period≥2 years) in primary prevention up to 65 years of age were recruited. Association between the triglyceride/HDL cholesterol (HDL-C) ratio and presence of carotid plaque, assessed by ultrasonography, was analyzed. ROC analysis was performed, determining the precision of this ratio to detect carotid plaque. RESULTS: A total of 332 women (age 57±5 years) were recruited. Triglyceride/HDL-C ratio was 2.35±1.6. Prevalence of carotid plaque was 29%. Women with carotid plaque had higher triglyceride/HDL-C ratios (3.33±1.96 vs. 2.1±1.2, P<.001) than women with no carotid plaque. A positive relationship was seen between quintiles of this ratio and prevalence of carotid plaque (p<.001). Regardless of other risk factors, women with higher triglyceride/HDL-C ratios were more likely to have carotid plaque (odds ratio 1.47, 95% confidence interval 1.20-1.79, P<.001). The area under the curve of the triglyceride/HDL-C ratio to detect carotid plaque was .71 (95% confidence interval .65 to .76), and the optimal cut-off point was 2.04. CONCLUSIONS: In postmenopausal women in primary prevention, insulin resistance, estimated from the triglyceride/HDL-C ratio, was independently associated to a greater probability of carotid plaque. A value of such ratio greater than 2 may be used for assessing cardiovascular risk in this particular group of women.


Assuntos
Doenças das Artérias Carótidas/sangue , HDL-Colesterol/sangue , Pós-Menopausa/sangue , Triglicerídeos/sangue , Argentina/epidemiologia , Biomarcadores , Estudos Transversais , Feminino , Humanos , Resistência à Insulina , Pessoa de Meia-Idade , Placa Aterosclerótica/sangue , Placa Aterosclerótica/diagnóstico por imagem , Prevalência , Curva ROC , Fatores de Risco , Ultrassonografia
18.
Int. j. morphol ; 39(2): 441-446, abr. 2021. ilus, tab
Artigo em Inglês | LILACS | ID: biblio-1385355

RESUMO

SUMMARY: There is evidence demonstrating the presence of functional compartmentalisation (FC) in some skeletal muscles. This means that the motor units (MU), grouped in certain areas of the muscle, show different levels of activation in comparison to those located in other zones. This has only been described in large muscles whose morphology proves the existence of a FC. However, there is no background information about small muscles, such as the Abductor digiti minimi manus (ADM). The objective of this study was to compare the activation of the MU in different zones of the ADM to support the hypothesis of the existence of a FC in the ADM. By using a cross- sectional, analytical, observational study, the activity of the MUs in the ADM was assessed in 12 volunteers (age 21 ± 1.6 years old; weight 75.3 ± 8 kg; height 176.2 ± 7.3 cm; average ± standard deviation). The activity of MUs was evaluated using high-density surface electromyography (HD-sEMG) with an array of 64 electrodes arranged two-dimensionally. This allowed us to record the activity of the MUs in three zones of the ADM (Z1: dorsal zone; Z2: dorsal-palmar zone and Z3: palmar zone). Electromyographic recordings were obtained during voluntary isometric contractions of the ADM at 20, 40, 60 and 80 % of the maximum voluntary contraction (MVC). The comparison of the activation levels of MUs between the three zones was carried out using a mixed model analysis of covariance. The results showed a significant difference between the dorsal and palmar zones at 40 % of the MVC (p= 0.03), and between the dorsal and dorsal- palmar zone at 80 % of the MVC (p= 0.03). The results obtained in the evaluated sample support the hypothesis of the existence of FC in the ADM. However, further research is needed to determine with greater certainty the presence of this compartmentalisation in the ADM.


RESUMEN: Existe evidencia que demuestra la presencia de una compartimentalización funcional (CF) en algunos músculos esqueléticos. Aquello se traduce en que las unidades motoras (UM) agrupadas en ciertas zonas del músculo, presentan diferentes niveles de activación a las ubicadas en otras regiones. Esto solo ha sido descrito en músculos grandes, cuya morfología justifica la existencia de una CF. Sin embargo, no existen antecedentes de aquello en músculos pequeños, tales como el abductor digiti minimi manus (ADM). El objetivo de este estudio fue comparar la activación de las UM en distintas zonas del ADM, con la finalidad sostener la hipótesis de la existencia de una CF en el ADM. Mediante un estudio observacional analítico transversal se evaluó la actividad de las UM del ADM en 12 voluntarios (edad 21±1,6 años; peso 75,3±8 kg; altura 176,2 ± 7,3 cm; promedio ± desviación estándar). La actividad de las UM, se evaluó mediante electromiografía de superficie alta densidad usando una matriz de 64 electrodos dispuestos bidimensionalmente. Esta permitió registrar la actividad de las UM en tres zonas del ADM (Z1: zona dorsal; Z2: zona dorso-palmar y Z3: zona palmar). Los registros electromiográficos fueron obtenidos durante contracciones isométricas voluntarias del ADM al 20, 40, 60 y 80 % de la contracción voluntaria máxima (CVM). La comparación de los niveles de activación de las UM entre las tres zonas fue realizada mediante un análisis de modelos mixtos de covarianza. Los resultados indicaron que existió diferencia significativa entre la zona dorsal y palmar al 40 % de la CVM (p=0,03), y entre la zona dorsal y dorso-palmar al 80 % de la CVM (p=0,03). Los resultados obtenidos en la muestra evaluada sostienen la hipótesis de la existencia de una CF en el ADM. Sin embargo, son necesarias más investigaciones para establecer con mayor certeza la presencia de esta compartimentalización en el ADM.


Assuntos
Humanos , Adulto Jovem , Músculo Esquelético/anatomia & histologia , Eletromiografia/métodos , Mãos/anatomia & histologia , Estudos Transversais , Músculo Esquelético/fisiologia , Mãos/fisiologia
19.
Clín. investig. arterioscler. (Ed. impr.) ; 33(3): 117-126, May-Jun. 2021. ilus, graf, tab
Artigo em Inglês | IBECS (Espanha) | ID: ibc-220986

RESUMO

Background: Bempedoic acid is a novel non-statin drug that was developed to treat hyperlipidemia in combination with other lipid-lowering drugs in those patients who need additional lipid lowering. Objectives: (1) To investigate the lipid efficacy of bempedoic acid; (2) to analyze the anti-inflammatory effects of bempedoic acid estimated through high sensitivity C-reactive protein (hsCRP). Methods: We performed a meta-analysis including randomized trials of bempedoic acid therapy, reporting low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), apolipoprotein B and hsCRP with a minimum of 4 weeks of follow-up. The primary endpoint was defined as the percentage change in lipids and hsCRP levels measured from baseline to follow-up, comparing groups of subjects on bempedoic acid versus placebo. Results: Seven eligible trials of bempedoic acid (3892 patients) were included. The bempedoic acid therapy was associated with a significant reduction in LDL-C levels [−20.3% (CI 95% −23.5 to −17.1)]; I2=43%]. Similarly, a significant percentage reduction in the apolipoprotein B levels [−14.3% (CI 95% −16.4 to −12.1)]; p<0.05; I2=46%], non-HDL-C levels [−15.5% (CI 95% −18.1 to −13.0)]; p<0.05; I2=53%] and hsCRP [−23.4% (CI 95% −32.6 to −14.2)]; p<0.05; I2=69%] was demonstrated with the bempedoic acid use. The sensitivity analysis showed that the results were robust. Conclusion: Our data suggests that the use of bempedoic acid significantly reduces the levels of all atherogenic lipid markers, including LDL-C, non-HDL-C and apolipoprotein B. Furthermore, considering hsCRP levels, the drug produces an anti-inflammatory effect.(AU)


Antecedentes: El ácido bempedoico es un fármaco nuevo no perteneciente al grupo de las estatinas, que fue desarrollado para tratar la hiperlipidemia, junto con otros fármacos liporreductores, en aquellos pacientes que necesitan una reducción lipídica adicional. Objetivos: (1) Estudiar la eficacia anti-lipídica del ácido bempedoico; (2) analizar los efectos antiinflamatorios del ácido bempedoico, calculados a través de la proteína C reactiva de alta sensibilidad (hsCRP). Métodos: Realizamos un meta-análisis incluyendo ensayos aleatorios de terapia de ácido bempedoico, reportando colesterol de lipoproteína de baja densidad (LDL-C), colesterol de lipoproteína de no alta densidad (no-HDL-C), apolipoproteína B y hsCRP con un mínimo de 4 semanas de seguimiento. El objetivo primario se definió como el cambio porcentual de lípidos y niveles de hsCRP medidos desde el inicio hasta el seguimiento, comparando los sujetos de los grupos ácido bempedoico frente a placebo. Resultados: Se incluyeron siete ensayos elegibles de ácido bempedoico (3.892 pacientes). La terapia de ácido bempedoico se asoció a una reducción significativa de los niveles de LDL-C [−20,3% (IC 95% de −23,5 a −17,1)]; I2 = 43%]. De igual modo, se demostró una reducción porcentual significativa de los niveles de apolipoproteína B [−14,3% (IC 95% de −16,4 a −12,1)]; p < 0,05; I2 = 46%], niveles de no-HDL-C [−15,5% (IC 95% de −18,1 a −13)]; p < 0,05; I2 = 53%] y hsCRP [−23.4% (IC 95% de −32,6 a −14,2)]; p < 0,05; I2 = 69%] con el uso de ácido bempedoico, reflejando el análisis de sensibilidad que los resultados eran sólidos. Conclusión: Nuestros datos sugieren que el uso de ácido bempedoico reduce significativamente los niveles de todos los marcadores lipídicos aterogénicos, incluyendo LDL-C, no-HDL-C y la apolipoproteína B. Además, considerando los niveles de hsCRP, el fármaco produce un efecto antiinflamatorio.(AU)


Assuntos
Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases , Hiperlipidemias , Apolipoproteína B-48 , Proteína C
20.
Rev Esp Cardiol (Engl Ed) ; 68(4): 305-9, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25278210

RESUMO

INTRODUCTION AND OBJECTIVES: Recent genome-wide association studies have identified a locus on chromosome 12q13.3 associated with plasma levels of triglyceride and high-density lipoprotein cholesterol, with rs11613352 being the lead single nucleotide polymorphism in this genome-wide association study locus. The aim of the study is to investigate the involvement of rs11613352 in a population with high cardiovascular risk due to familial hypercholesterolemia. METHODS: The single nucleotide polymorphism was genotyped by Taqman(®) assay in a cohort of 601 unrelated familial hypercholesterolemia patients and its association with plasma triglyceride and high-density lipoprotein cholesterol levels was analyzed by multivariate methods based on linear regression. RESULTS: Minimal allele frequency was 0.17 and genotype frequencies were 0.69, 0.27, and 0.04 for CC, CT, and TT genotypes, respectively. The polymorphism is associated in a recessive manner (TT genotype) with a decrease in triglyceride levels (P=.002) and with an increase in high-density lipoprotein cholesterol levels (P=.021) after adjusting by age and sex. CONCLUSIONS: The polymorphism rs11613352 may contribute to modulate the cardiovascular risk by modifying plasma lipid levels in familial hypercholesterolemia patients.


Assuntos
HDL-Colesterol/sangue , DNA/genética , Hiperlipoproteinemia Tipo II/genética , Polimorfismo de Nucleotídeo Único , Triglicerídeos/sangue , Adulto , Feminino , Frequência do Gene , Estudo de Associação Genômica Ampla , Genótipo , Humanos , Hiperlipoproteinemia Tipo II/sangue , Masculino , Pessoa de Meia-Idade , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa